Trial Profile
XELOX(+bevacizumab), efficacy, safety, QOL Study:FOLFOX(+bevacizumab) after starting therapy, for patients can't continue continuous infusion therapy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Oxaliplatin (Primary) ; Bevacizumab; Fluorouracil; Folinic acid
- Indications Colorectal cancer
- Focus Therapeutic Use
- 04 Aug 2011 New trial record